Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Polatuzumab Vedotin Plus Rituximab, Gemcitabine, and Oxaliplatin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Results From the Phase III, Randomized POLARGO Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Interim assessment by circulating tumor DNA in primary mediastinal large B-cell lymphoma: a multicenter LYSA study.

Blood advances·2026
Same author

Peri-Operative Detection of Circulating Tumor DNA Using a Customized NGS Tumor-Informed Assay in Patients With HPV-Negative Locally Advanced Head and Neck Squamous Cell Carcinoma.

International journal of cancer·2026
Same author

Genome-wide association study of event-free survival in follicular lymphoma patients treated with front-line immunochemotherapy.

Blood cancer journal·2026
Same author

FLIPI24: A Modern Prognostic Model and Clinical Trial Enrichment Tool for Newly Diagnosed Follicular Lymphoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2025
Same author

Early positron emission tomography response-adapted treatment in low-risk diffuse large B-cell lymphoma: an open-label, multicenter, randomized, noninferiority phase III trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2025

Related Experiment Video

Updated: Jan 5, 2026

Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

11.9K

Refining diffuse large B-cell lymphoma subgroups using integrated analysis of molecular profiles.

Sydney Dubois1, Bruno Tesson2, Sylvain Mareschal3

  • 1Inserm U1245, Centre Henri Becquerel, Université de Rouen, IRIB, Rouen, France.

Ebiomedicine
|October 26, 2019
PubMed
Summary

This study integrated genomic and expression data to refine Diffuse Large B-cell Lymphoma (DLBCL) subtypes. Analysis revealed significant heterogeneity and identified a specific genomic alteration linked to poorer outcomes in DLBCL patients.

Keywords:
Diffuse large B-cell lymphomaGene signatures, prognosisIndependent component analysisTranscriptomic variability

More Related Videos

Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma
07:52

Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma

Published on: January 9, 2019

20.4K
VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
15:07

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

Published on: December 28, 2015

27.2K

Related Experiment Videos

Last Updated: Jan 5, 2026

Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

11.9K
Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma
07:52

Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma

Published on: January 9, 2019

20.4K
VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
15:07

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

Published on: December 28, 2015

27.2K

Area of Science:

  • Genomics
  • Molecular Biology
  • Oncology

Background:

  • Diffuse Large B-cell Lymphoma (DLBCL) characterization has advanced with gene expression profiling (GEP), next-generation sequencing (NGS), and copy number variation (CNV) analysis.
  • Previous studies have detailed genomic profiles, but a fully integrated analysis is needed to refine DLBCL subtypes.
  • This study compares its model to existing DLBCL classifiers to reflect the current state of genomic subtypes.

Purpose of the Study:

  • To perform an integrated analysis of mutational, genomic, and expression profiles in DLBCL.
  • To refine the classification of DLBCL subtypes using multi-level molecular data.
  • To compare the developed model with existing DLBCL classifiers.

Main Methods:

  • Analysis of 223 de novo DLBCL patients from the LNH-03B LYSA clinical trials.
  • Acquisition of GEP data via Affymetrix GeneChip arrays, mutational profiles via Lymphopanel NGS, and CNV analysis via array CGH.
  • Application of unsupervised independent component analysis (ICA) to GEP data and integrated analysis of associated multi-level molecular data.

Main Results:

  • ICA identified 38 components representing transcriptomic variability in the DLBCL cohort.
  • Components correlated with known DLBCL features like cell-of-origin, stromal, and MYC signatures.
  • A component linked to 19q13 gain was significantly associated with poor overall survival (OS) and progression-free survival (PFS), highlighting heterogeneity within DLBCL subtypes.

Conclusions:

  • Integrated analysis provides a global, multi-level view of DLBCL.
  • Enhanced understanding of DLBCL subgroups is achieved through this comprehensive approach.
  • The study refines DLBCL classification by integrating diverse molecular data.